These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 9433651

  • 1. Effect of age and gender on the pharmacokinetics of grepafloxacin.
    Efthymiopoulos C, Bramer SL, Maroli A.
    Clin Pharmacokinet; 1997; 33 Suppl 1():9-17. PubMed ID: 9433651
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males.
    Efthymiopoulos C, Bramer SL, Maroli A.
    Clin Pharmacokinet; 1997; 33 Suppl 1():1-8. PubMed ID: 9433650
    [Abstract] [Full Text] [Related]

  • 3. Grepafloxacin pharmacokinetics in individuals with hepatic dysfunction.
    Efthymiopoulos C, Bramer SL, Maroli A, Flaherty JF, Wolfe E, Bass N, Somberg K.
    Clin Pharmacokinet; 1997; 33 Suppl 1():25-31. PubMed ID: 9433653
    [Abstract] [Full Text] [Related]

  • 4. Effect of renal impairment on the pharmacokinetics of grepafloxacin.
    Efthymiopoulos C, Bramer SL, Maroli A, Gambertoglio JG.
    Clin Pharmacokinet; 1997; 33 Suppl 1():32-8. PubMed ID: 9433654
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of grepafloxacin.
    Efthymiopoulos C.
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():35-43. PubMed ID: 9484872
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects.
    Kozawa O, Uematsu T, Matsuno H, Niwa M, Nagashima S, Kanamaru M.
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2824-8. PubMed ID: 9124849
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The influence of age on the pharmacokinetics of temafloxacin.
    Granneman GR, Guay DR.
    Am J Med; 1991 Dec 30; 91(6A):71S-75S. PubMed ID: 1662898
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Multiple-dose pharmacokinetics of rufloxacin in patients with cirrhosis.
    Triger DR, Granai F, Woodcock J, Wise R, Imbimbo BP.
    Hepatology; 1993 Oct 30; 18(4):847-52. PubMed ID: 8406358
    [Abstract] [Full Text] [Related]

  • 15. The influence of age and gender on the pharmacokinetics of moxifloxacin.
    Sullivan JT, Lettieri JT, Liu P, Heller AH.
    Clin Pharmacokinet; 2001 Oct 30; 40 Suppl 1():11-8. PubMed ID: 11352437
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis.
    Forrest A, Chodosh S, Amantea MA, Collins DA, Schentag JJ.
    J Antimicrob Chemother; 1997 Dec 30; 40 Suppl A():45-57. PubMed ID: 9484873
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of temafloxacin after multiple oral administration.
    Granneman GR.
    Clin Pharmacokinet; 1992 Dec 30; 22 Suppl 1():14-23. PubMed ID: 1319867
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and ocular penetration of grepafloxacin in albino and pigmented rabbits.
    Perez S, Solans C, Bregante MA, Pinilla I, García MA, Honrubia F.
    J Antimicrob Chemother; 2002 Oct 30; 50(4):541-5. PubMed ID: 12356799
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of rufloxacin in healthy volunteers after repeated oral doses.
    Mattina R, Bonfiglio G, Cocuzza CE, Gulisano G, Cesana M, Imbimbo BP.
    Chemotherapy; 1991 Oct 30; 37(6):389-97. PubMed ID: 1662127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.